These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML]. Jehn U, Dengler R, Petrides PE. Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003 [No Abstract] [Full Text] [Related]
3. [II. Leukemia in the elderly, secondary, recurrent and refractory leukemia, chloroma]. Jehn U, Dengler R, Petrides PE. Internist (Berl); 1996 Jun; 37(6):669-77. PubMed ID: 8768004 [No Abstract] [Full Text] [Related]
7. [Current situation and perspective for treatment of acute myelogenous leukemia in adults]. Fukushima T, Ueda T. Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819 [Abstract] [Full Text] [Related]
8. "Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment. Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Semin Hematol; 1991 Jul; 28(3 Suppl 4):44-7. PubMed ID: 1780752 [No Abstract] [Full Text] [Related]
9. Treatment for adult acute myeloid leukemia: where we stand in 1995. Wiernik PH. Acta Haematol Pol; 1995 Jul; 26(3):231-7. PubMed ID: 8525767 [No Abstract] [Full Text] [Related]
10. [Acute leukemia in childhood]. Fink FM, Gadner H. Wien Med Wochenschr; 1991 Jul; 141(9-10):190-5. PubMed ID: 1949840 [Abstract] [Full Text] [Related]
15. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]. Hübner G, Link H, Schönrock-Nabulsi P, Wandt H, Gramatzki M, Löffler B, Fackler-Schwalbe I, Queisser W, Brack N, Geer T, Raab M, Ohl S, Schneider B, Schneider C, Freund M, Poliwoda H, Ehninger G. Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():26-32. PubMed ID: 8692115 [Abstract] [Full Text] [Related]
16. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia. de Witte T, Hermans J, van Biezen A, Vernant J, Kolb H, Zwaan F, Vossen J, Lönnqvist B, Beelen D, Ferrant A. Bone Marrow Transplant; 1991 Apr 12; 7 Suppl 2():40. PubMed ID: 1878713 [No Abstract] [Full Text] [Related]
17. Progress toward predictive models for the outcome of treatment for acute nonlymphocytic leukemia. Preisler HD, Raza A. Oncology (Williston Park); 1987 May 12; 1(3):49-59, 62. PubMed ID: 3079480 [Abstract] [Full Text] [Related]
19. Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative Group. Willemze R, Zittoun R, Mandelli F, Tura S, de Witte T, Stryckmans P, Suciu S, Solbu G. Bone Marrow Transplant; 1989 Dec 21; 4 Suppl 3():72. PubMed ID: 2697406 [No Abstract] [Full Text] [Related]
20. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK. Rees JK, Gray RG. Bone Marrow Transplant; 1989 Dec 21; 4 Suppl 3():70-1. PubMed ID: 2697405 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]